Concord Drugs Ltd

₹ 82.3 2.34%

05 Jun - close price

About

Incorporated in 1995, Concord Drugs Ltd manufactures licensed drugs based on
approved formulations

Key Points

Product Portfolio:^[1]
a) Pharmaceutical Ready to fill Pellets
b) Multiple Unit Pellet System (MUPS)
c) Tissue Bio Adhesive
d) Injectables (Small Volume Parenterals)
e) Oral Solid Dosages (Tablets & Capsules)
f) Liquid Orals (Syrups & Suspensions)
g) Dry Syrup (Powder)

Website BSE

Market Cap ₹ 108 Cr.
Current Price ₹ 82.3
High / Low ₹ 92.5 / 29.0
Stock P/E 102
Book Value ₹ 36.8
Dividend Yield 0.00 %
ROCE 5.51 %
ROE 2.57 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company has reduced debt.
Company is expected to give good quarter

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Company has low interest coverage ratio.
Company has a low return on equity of 1.73% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	12.31	8.98	7.53	12.78	15.64	11.69	12.37	10.80	10.39	13.61	10.28	16.99	37.90
	11.34	7.52	5.91	12.15	15.29	10.86	11.49	9.40	9.34	12.59	9.18	16.05	36.40
Operating Profit	0.97	1.46	1.62	0.63	0.35	0.83	0.88	1.40	1.05	1.02	1.10	0.94	1.50
OPM %	7.88%	16.26%	21.51%	4.93%	2.24%	7.10%	7.11%	12.96%	10.11%	7.49%	10.70%	5.53%	3.96%
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest	0.50	0.44	0.43	0.50	0.50	0.45	0.47	0.50	0.61	0.49	0.49	0.34	0.40
Depreciation	0.33	0.38	0.39	0.39	0.39	0.34	0.34	0.37	0.38	0.37	0.34	0.31	0.35
Profit before tax	0.14	0.64	0.80	-0.26	-0.54	0.04	0.07	0.53	0.06	0.16	0.27	0.29	0.75
Tax %	-21.43%	23.44%	30.00%	-3.85%	-38.89%	50.00%	42.86%	58.49%	33.33%	25.00%	29.63%	27.59%	29.33%
	0.16	0.49	0.56	-0.24	-0.34	0.03	0.04	0.23	0.04	0.12	0.19	0.22	0.53
EPS in Rs	0.17	0.53	0.60	-0.24	-0.34	0.03	0.04	0.23	0.04	0.12	0.19	0.17	0.40
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	58.96	52.08	44.92	45.24	78.77
	53.37	47.51	40.88	41.10	74.22
Operating Profit	5.59	4.57	4.04	4.14	4.55
OPM %	9.48%	8.77%	8.99%	9.15%	5.78%
	0.10	0.01	0.01	0.01	0.00
Interest	1.68	1.71	1.87	2.03	1.71
Depreciation	1.76	1.63	1.56	1.43	1.37
Profit before tax	2.25	1.24	0.62	0.69	1.47
Tax %	28.89%	20.97%	25.81%	50.72%	28.57%
	1.59	0.99	0.47	0.34	1.06
EPS in Rs	1.82	1.06	0.47	0.34	0.80
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	15%
TTM:	74%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	2%
TTM:	212%

Stock Price CAGR
10 Years:	5%
5 Years:	18%
3 Years:	45%
1 Year:	159%

Return on Equity
10 Years:	%
5 Years:	3%
3 Years:	2%
Last Year:	3%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	8.74	9.32	10.00	10.00	13.18
Reserves	19.62	22.38	23.82	24.11	35.34
	16.43	16.96	17.52	19.24	13.60
	11.66	9.57	7.46	11.80	12.77
Total Liabilities	56.45	58.23	58.80	65.15	74.89
	13.97	12.92	11.68	12.21	11.58
CWIP	0.55	0.92	1.63	2.00	2.43
Investments	0.00	0.89	0.84	0.80	0.78
	41.93	43.50	44.65	50.14	60.10
Total Assets	56.45	58.23	58.80	65.15	74.89

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	0.77	1.66	0.79	3.72	-6.77
	-2.44	-2.27	-1.01	-2.32	-1.13
	1.68	0.62	0.28	-1.43	8.06
Net Cash Flow	0.01	0.02	0.07	-0.02	0.16
Free Cash Flow	-1.69	0.80	-0.23	1.39	-7.94
CFO/OP	26%	45%	25%	95%	-140%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	141.52	110.80	103.44	109.73	112.97
Inventory Days	151.64	178.58	251.53	261.81	137.69
Days Payable	62.25	46.92	34.02	78.95	38.15
Cash Conversion Cycle	230.90	242.47	320.95	292.59	212.52
Working Capital Days	112.48	152.43	132.77	115.78	145.92
ROCE %		6.31%	4.98%	5.20%	5.51%

Insights

In beta

Mar 2015

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Consolidated Revenue from Operations
INR Lakhs

x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx
	x	x	x	x	x	x	x		x	x
			xx	xx	xxx	xxx	xxx	xxx	xxx	xxx

Please log in to see hidden values.

Operational Divisions Count
Number ・Standalone data

Number of Employees
Count ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	52.13%	52.13%	55.41%	55.41%	55.41%	54.39%	54.39%	54.39%	54.39%	54.39%	54.39%	54.39%
	47.87%	47.87%	44.59%	44.60%	44.60%	45.61%	45.61%	45.61%	45.61%	45.61%	45.61%	45.61%
No. of Shareholders	3,198	3,957	4,032	4,734	4,755	5,073	5,073	5,252	5,189	4,718	4,597	4,464

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	39.21%	38.90%	38.93%	42.78%	44.38%	49.00%	52.13%	55.41%	54.39%	54.39%
	60.79%	61.10%	61.07%	57.22%	55.62%	51.00%	47.87%	44.60%	45.61%	45.61%
No. of Shareholders	1,623	1,833	2,019	1,985	2,173	3,047	3,204	4,734	5,252	4,464

Concord Drugs Ltd

Concord Drugs Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Insights

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings